|
DK178590D0
(da)
|
1990-07-26 |
1990-07-26 |
Novo Nordisk As |
1,4-disubstituerede piperaziner
|
|
PT100905A
(pt)
|
1991-09-30 |
1994-02-28 |
Eisai Co Ltd |
Compostos heterociclicos azotados biciclicos contendo aneis de benzeno, ciclo-hexano ou piridina e de pirimidina, piridina ou imidazol substituidos e composicoes farmaceuticas que os contem
|
|
CA2400368A1
(en)
|
1992-12-02 |
1994-06-09 |
Allen J. Duplantier |
Catechol diethers as selective pde iv inhibitors
|
|
DE4323192A1
(de)
|
1993-07-10 |
1995-01-12 |
Basf Ag |
Verfahren zur Herstellung von Homo- und Copolymerisaten von Alk-1-enen
|
|
DE4325846C1
(de)
|
1993-07-31 |
1995-01-19 |
Herberts Gmbh |
Verwendung von Furan-modifizierten aromatischen Pinakolderivaten als Initiatoren und Furan-modifizierte aromatische Pinakolderivate als solche
|
|
DE4343286A1
(de)
|
1993-12-17 |
1995-06-22 |
Hoechst Ag |
Heteroaromatische Verbindungen und ihre Verwendung in flüssigkristallinen Mischungen
|
|
DE4409501A1
(de)
|
1994-03-19 |
1995-09-21 |
Didier Werke Ag |
Verschleißfutter eines Schachtofens und Stein hierfür
|
|
WO1996000218A1
(en)
|
1994-06-24 |
1996-01-04 |
Euro-Celtique, S.A. |
Compounds for and method of inhibiting phosphodiesterase iv
|
|
US5789434A
(en)
|
1994-11-15 |
1998-08-04 |
Bayer Corporation |
Derivatives of substituted 4-biarylbutyric acid as matrix metalloprotease inhibitors
|
|
TW424087B
(en)
|
1995-04-06 |
2001-03-01 |
Janssen Pharmaceutica Nv |
1,3-dihydro-1-(phenylalkenyl)-2H-imidazol-2-one derivatives
|
|
TW332201B
(en)
|
1995-04-06 |
1998-05-21 |
Janssen Pharmaceutica Nv |
1,3-Dihydro-1-(phenylalkyl)-2H-imidazol-2-one derivatives
|
|
US6037370A
(en)
|
1995-06-08 |
2000-03-14 |
Vertex Pharmaceuticals Incorporated |
Methods and compositions for stimulating neurite growth
|
|
EP1170009B1
(en)
|
1996-01-22 |
2004-04-07 |
Fujisawa Pharmaceutical Co., Ltd. |
Thiazolybenzofuran derivatives and their use as SRS-A and leukotiene antagonists
|
|
WO1998008830A1
(de)
|
1996-08-26 |
1998-03-05 |
Byk Gulden Lomberg Chemische Fabrik Gmbh |
Thiazol-derivate als selektive inhibitoren der pde-iv
|
|
JPH1087543A
(ja)
|
1996-09-17 |
1998-04-07 |
Chisso Corp |
アルコキシベンゼン誘導体、液晶組成物および液晶表示素子
|
|
US6548490B1
(en)
|
1997-10-28 |
2003-04-15 |
Vivus, Inc. |
Transmucosal administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction
|
|
WO1999045914A1
(en)
|
1998-03-13 |
1999-09-16 |
Maruho Kabushikikaisha |
Alkyl amine derivative and local anesthetic agent using the same
|
|
GB9807354D0
(en)
|
1998-04-07 |
1998-06-03 |
Glaxo Group Ltd |
Antiviral compound
|
|
SE9804212D0
(sv)
|
1998-12-04 |
1998-12-04 |
Astra Pharma Prod |
Compounds
|
|
SK12832001A3
(sk)
|
1999-03-12 |
2002-01-07 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Protizápalové látky, spôsob ich výroby, farmaceutický prostriedok s ich obsahom a ich použitie
|
|
US7141593B1
(en)
|
1999-06-04 |
2006-11-28 |
Abbott Laboratories |
Pharmaceutical formulations
|
|
GB9929552D0
(en)
|
1999-12-14 |
2000-02-09 |
Proteus Molecular Design |
Compounds
|
|
WO2001096334A2
(en)
|
2000-06-15 |
2001-12-20 |
Pharmacia Corporation |
Heteroarylalkanoic acids as integrin receptor antagonists
|
|
US20030032579A1
(en)
|
2001-04-20 |
2003-02-13 |
Pfizer Inc. |
Therapeutic use of selective PDE10 inhibitors
|
|
YU91603A
(sh)
|
2001-05-22 |
2006-08-17 |
Pfizer Products Inc. |
Kristalni oblici azitromicina
|
|
EP1499662A1
(en)
*
|
2002-04-18 |
2005-01-26 |
Avecia Limited |
Prepation of a conjugated molecule and materials for use therein
|
|
US6821502B2
(en)
|
2002-06-12 |
2004-11-23 |
Chevron U.S.A. Inc. |
Method of making aluminum-containing zeolite with IFR structure
|
|
CN1681763A
(zh)
|
2002-07-27 |
2005-10-12 |
阿斯特拉曾尼卡有限公司 |
化合物
|
|
EA008767B1
(ru)
|
2002-10-08 |
2007-08-31 |
Зе Скрипс Ресеч Инститьют |
Ингибиторы гидролазы амидов жирных кислот
|
|
ES2315546T3
(es)
|
2002-10-30 |
2009-04-01 |
Via Pharmaceuticals, Inc. |
Inhibidores delas fosfodiesterasas de los nucleotidos ciclicos, que presentan una estructura de benzodiazepina, y su uso en terapia.
|
|
TW200410921A
(en)
|
2002-11-25 |
2004-07-01 |
Hoffmann La Roche |
Mandelic acid derivatives
|
|
AU2003289200A1
(en)
|
2002-12-06 |
2004-06-30 |
Kowa Co., Ltd. |
Erythropoietin production accelerator
|
|
CA2507699A1
(en)
|
2002-12-20 |
2004-07-15 |
Pharmacia Corporation |
Heteroarylalkanoic acids as integrin receptor antagonists
|
|
WO2004071509A1
(ja)
|
2003-02-12 |
2004-08-26 |
Nippon Chemiphar Co., Ltd. |
オリゴデンドロサイト分化促進剤
|
|
EP1631568A1
(en)
|
2003-04-18 |
2006-03-08 |
Memory Pharmaceuticals Corporation |
Pyrazole derivatives as phosphodiesterase 4 inhibitors
|
|
AR047541A1
(es)
|
2004-02-13 |
2006-01-25 |
Sandoz Ag |
Fosfato de 5-[[4-[2-metil-2-piridinil-amino-etoxi]fenil]metil]-2,4 tiazolidinadiona (rosiglitazona) y sus formas polimorficas
|
|
NZ550114A
(en)
|
2004-04-20 |
2011-02-25 |
Transtech Pharma Inc |
Substituted thiazole and pyrimidine derivatives as melanocortin receptor modulators
|
|
EP1753428A4
(en)
*
|
2004-05-14 |
2010-09-15 |
Abbott Lab |
INHIBITORS OF KINASES AS THERAPEUTIC AGENTS
|
|
US7351833B2
(en)
|
2004-07-23 |
2008-04-01 |
Abbott Laboratories |
(1S,5S)-3-(5,6-dichloropyridin-3-yl)-3,6-diazabicyclo[3.2.0]heptane benzenesulfonate
|
|
US7449486B2
(en)
*
|
2004-10-19 |
2008-11-11 |
Array Biopharma Inc. |
Mitotic kinesin inhibitors and methods of use thereof
|
|
US8436176B2
(en)
|
2004-12-30 |
2013-05-07 |
Medicis Pharmaceutical Corporation |
Process for preparing 2-methyl-1-(2-methylpropyl)-1H-imidazo[4,5-c][1,5]naphthyridin-4-amine
|
|
RS51385B
(sr)
|
2005-01-07 |
2011-02-28 |
Pfizer Products Inc. |
Heteroaromatična jedinjenja hinolina i njihova upotreba kao pde10 inhibitora
|
|
EP1850681B1
(en)
|
2005-02-04 |
2019-12-18 |
Firmenich Incorporated |
Compounds comprising linked hetero aryl moieties and their use as novel umami flavor modifiers, tastants and taste enhancers for comestible compositions
|
|
US20060252807A1
(en)
|
2005-04-22 |
2006-11-09 |
Kalypsys, Inc. |
Novel ortho-terphenyl inhibitors of p38 kinase and methods of treating inflammatory disorders
|
|
UA91546C2
(uk)
|
2005-05-03 |
2010-08-10 |
Бьорінгер Інгельхайм Інтернаціональ Гмбх |
КРИСТАЛІЧНА ФОРМА 1-ХЛОР-4-(β-D-ГЛЮКОПІРАНОЗ-1-ИЛ)-2-[4-((S)-ТЕТРАГІДРОФУРАН-3-ІЛОКСИ)-БЕНЗИЛ]-БЕНЗОЛУ, СПОСІБ ЇЇ ОДЕРЖАННЯ ТА ЇЇ ЗАСТОСУВАННЯ ПРИ ПРИГОТУВАННІ ЛІКАРСЬКИХ ЗАСОБІВ
|
|
MY152185A
(en)
|
2005-06-10 |
2014-08-29 |
Novartis Ag |
Modified release 1-[(3-hydroxy-adamant-1-ylamino)-acetyl]-pyrrolidine-2(s)-carbonitrile formulation
|
|
US20070032531A1
(en)
|
2005-08-04 |
2007-02-08 |
Apogee Biotechnology Corporation |
Sphingosine kinase inhibitors and methods of their use
|
|
KR20080050577A
(ko)
|
2005-08-29 |
2008-06-09 |
사노피-아벤티스 유.에스. 엘엘씨 |
피리다지노[4,5-ｂ]인돌 유도체의 신규 결정질 형태
|
|
EP2119723A1
(en)
|
2005-09-13 |
2009-11-18 |
Sicor, Inc. |
Processes for the synthesis of rocuronium bromide
|
|
US8637559B2
(en)
|
2005-11-15 |
2014-01-28 |
Otsuka Pharmaceutical Co., Ltd. |
Oxazole compound and pharmaceutical composition
|
|
AU2006327316A1
(en)
|
2005-12-23 |
2007-06-28 |
Astrazeneca Ab |
Imidazoles as GABA-B receptor modulators
|
|
JP2009535394A
(ja)
|
2006-05-02 |
2009-10-01 |
ファイザー・プロダクツ・インク |
Ｐｄｅ１０阻害剤としての二環式ヘテロアリール化合物
|
|
US20080090834A1
(en)
|
2006-07-06 |
2008-04-17 |
Pfizer Inc |
Selective azole pde10a inhibitor compounds
|
|
EP2059234B1
(en)
|
2006-09-08 |
2011-11-02 |
Ore Pharmaceuticals Inc. |
Method for reducing or alleviating inflammation in the digestive tract
|
|
MX2009003160A
(es)
|
2006-09-25 |
2009-04-06 |
Ptc Therapeutics Inc |
Formas cristalinas del acido 3-[5-(2-fluorofenil)-[1,2,4]oxadiazol -3-il]-benzoico.
|
|
AU2007300532A1
(en)
|
2006-09-28 |
2008-04-03 |
Merck Sharp & Dohme Corp. |
Pharmaceutical compositions of HDAC inhibitors and chelatable metal compounds, and metal-HDAC inhibitor chelate complexes
|
|
WO2008040669A2
(en)
|
2006-10-02 |
2008-04-10 |
Janssen Pharmaceutica N.V. |
Novel intermediates for the preparation of a glyt1 inhibitor
|
|
US7837978B2
(en)
|
2006-10-13 |
2010-11-23 |
Chevron U.S.A. Inc. |
Process for preparing aluminum-containing molecular sieve SSZ-26
|
|
ES2624791T3
(es)
*
|
2006-11-21 |
2017-07-17 |
Omeros Corporation |
Inhibidores de PDE10 y composiciones y métodos relacionados
|
|
US7786139B2
(en)
*
|
2006-11-21 |
2010-08-31 |
Omeros Corporation |
PDE10 inhibitors and related compositions and methods
|
|
PE20081506A1
(es)
|
2006-12-12 |
2008-12-09 |
Infinity Discovery Inc |
Formulaciones de ansamicina
|
|
WO2009008906A2
(en)
|
2007-02-06 |
2009-01-15 |
The Trustees Of The University Of Pennsylvania |
Therapeutic compounds for blocking dna synthesis of pox viruses
|
|
AU2008253803A1
(en)
|
2007-05-22 |
2008-11-27 |
Ultimorphix Technolgies B.V. |
Tenofovir disoproxil hemi-fumaric acid Co-crystal
|
|
EP2017264A1
(de)
|
2007-07-16 |
2009-01-21 |
Bayer Cropscience Ag |
Substituierte Phenylpropargylverbindungen, Verfahren zu deren Herstellung und deren Verwendung als Herbizide und Pflanzenwachstumsregulatoren
|
|
WO2009049022A1
(en)
|
2007-10-10 |
2009-04-16 |
Ore Pharmaceuticals Inc. |
Method for treatment of pancreatitis
|
|
TW200944520A
(en)
|
2008-01-29 |
2009-11-01 |
Glaxo Group Ltd |
Spiro compounds as NPY Y5 receptor antagonists
|
|
WO2009143178A2
(en)
|
2008-05-20 |
2009-11-26 |
Omeros Corporation |
Pde10 inhibitors and related compositions and methods
|
|
TWI501965B
(zh)
|
2008-06-20 |
2015-10-01 |
Lundbeck & Co As H |
作為ｐｄｅ１０ａ酵素抑制劑之新穎苯基咪唑衍生物
|
|
EP2310016B1
(en)
*
|
2008-08-05 |
2017-10-04 |
Omeros Corporation |
Pde10 inhibitors and related compositions and methods
|
|
JP5674828B2
(ja)
*
|
2010-03-12 |
2015-02-25 |
オメロス コーポレーション |
Ｐｄｅ１０インヒビターならびに関連する組成物および方法
|
|
NZ716462A
(en)
*
|
2014-04-28 |
2017-11-24 |
Omeros Corp |
Optically active pde10 inhibitor
|